BNTC
Benitec Biopharma·NASDAQ
--
--(--)
--
--(--)
BNTC Filings
Filing Date
Form Description
Form Type
2026-03-20
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
Financials
2026-03-20 · Financials
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
2026-02-12
Form 8-K - Current report
Key Events
2026-02-12 · Key Events
Form 8-K - Current report
2026-02-12
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Financials
2026-02-12 · Financials
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026-02-11
Form 424B3 - Prospectus [Rule 424(b)(3)]
2026-02-11 ·
Form 424B3 - Prospectus [Rule 424(b)(3)]
2026-02-11
Form EFFECT - Notice of Effectiveness
2026-02-11 ·
Form EFFECT - Notice of Effectiveness
2026-01-30
Form S-3 - Registration statement under Securities Act of 1933
2026-01-30 ·
Form S-3 - Registration statement under Securities Act of 1933
2026-01-29
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026-01-29 ·
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026-01-26
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2026-01-26 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2025-12-22
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2025-12-22 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2025-12-08
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2025-12-08 ·
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
